Istituto Biochimico Italiano Giovanni Lorenzini S P A

FDA Filings

This page includes the latest FDA filings for Istituto Biochimico Italiano Giovanni Lorenzini S P A. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Registration(s)

FDA Filings

Device
Company
DeviceDate
WG Critical Care, LLC, Istituto Biochimico Italiano Giovanni Lorenzini SpA
Prescription Medication2024-12-06
Fresenius Kabi USA, LLC, Istituto Biochimico Italiano Giovanni Lorenzini
Prescription Medication2024-10-23
WG Critical Care, LLC, Istituto Biochimico Italiano Giovanni Lorenzini SpA
Prescription Medication2024-03-16
WG Critical Care, LLC, Istituto Biochimico Italiano Giovanni Lorenzini SpA
Prescription Medication2024-02-02
WG Critical Care, LLC, Istituto Biochimico Italiano Giovanni Lorenzini SpA
Prescription Medication2023-01-10
WG Critical Care, LLC, Istituto Biochimico Italiano Giovanni Lorenzini SpA
Prescription Medication2021-08-24
Fresenius Kabi USA, LLC, Istituto Biochimico Italiano Giovanni Lorenzini
Prescription Medication2020-01-25
WG Critical Care, LLC, Istituto Biochimico Italiano Giovanni Lorenzini SpA
Prescription Medication2020-01-22
Sandoz Inc, Istituto Biochimico Italiano Giovanni Lorenzini SpA
Prescription Medication2019-12-20
Sandoz Inc, Istituto Biochimico Italiano Giovanni Lorenzini SpA
Prescription Medication2019-12-17
WG Critical Care, LLC, Istituto Biochimico Italiano Giovanni Lorenzini SpA
Prescription Medication2018-12-04
Fresenius Kabi USA, LLC, Istituto Biochimico Italiano Giovanni Lorenzini
Prescription Medication2018-09-06
Sandoz Inc, Istituto Biochimico Italiano Giovanni Lorenzini SpA
Prescription Medication2016-03-17
Sandoz Inc, Istituto Biochimico Italiano Giovanni Lorenzini SpA
Prescription Medication2014-06-02

Similar & Related FDA Registered Companies

Related Finance Registrations

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.